Novartis
NVS
#47
Rank
$205.83 B
Marketcap
$97.11
Share price
0.89%
Change (1 day)
6.78%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - P/B ratio

P/B ratio as of June 2023 : 3.95

According to Novartis's latest financial reports the company has a price-to-book ratio of 3.95.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Novartis - P/B ratio (from 2001 to 2022)

P/B ratio by year

Year P/B ratio Change
2022-12-313.2813.36%
2021-12-312.90-24.62%
2020-12-313.84-0.63%
2019-12-313.8754.26%
2018-12-312.51-5.63%
2017-12-312.6615.01%
2016-12-312.31-14.55%
2015-12-312.70-14.52%
2014-12-313.1620.99%
2013-12-312.6118.76%
2012-12-312.205.09%
2011-12-312.098.56%
2010-12-311.93-11.35%
2009-12-312.18-2.62%
2008-12-312.23-10.26%
2007-12-312.49-23.78%
2006-12-313.27-11.63%
2005-12-313.702.23%
2004-12-313.62-2.56%
2003-12-313.7115.97%
2002-12-313.20

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
5.23 32.47%๐Ÿ‡บ๐Ÿ‡ธ USA
2.24-43.30%๐Ÿ‡บ๐Ÿ‡ธ USA
4.84 22.72%๐Ÿ‡บ๐Ÿ‡ธ USA
1.57-60.33%๐Ÿ‡ซ๐Ÿ‡ท France
6.11 54.86%๐Ÿ‡บ๐Ÿ‡ธ USA
4.26 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
6.40 62.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.98 26.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
0.9546-75.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel